Oslo-based Tribune Therapeutics has raised $40 million to advance its way of inhibiting the formation of scar tissue in disease. The cash from investors including LifeArc Ventures, Novo Holdings, and ...
The Brighterside of News on MSN5d
Revolutionary new drug is a major breakthrough in diabetes careDiabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...
Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...
Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.
Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.
Kohen's team explored pirfenidone (PFD) for its antifibrotic activity, aiming to reduce scarring around GDDs without the toxicity of mitomycin C and 5-fluorouracil. A polymeric GDD sheath using PCL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback